Taken together, our study not only provided a supporting evidence for the anti-metastasis activities of CP against HBV-associated HCC, but it also addressed the novel role of Cav-1 in mediating the Akt/GSK3β/β-catenin axis during advanced cancer stages. The gene discussed is CAV1; the disease is cancer.